ArticleOrganic process research & development2026
Extracting Mechanistic Information from an Open Data Set for a Pharma-Relevant Suzuki-Miyaura Cross-Coupling Reaction.
Article in Organic process research & development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Open reaction data sets, particularly those gathered through high-throughput experimental (HTE) reaction screening campaigns, hold considerable value in downstream data analysis and reaction understanding. Data can be used to reveal important trends. Such open reaction data are increasingly being reported and deposited to appropriate databases, particularly for the most popular chemical reactions, e.g., Suzuki-Miyaura cross-coupling (SMCC) of organohalides and organoboron compounds, catalyzed by Pd and mediated by a suitable base. While there is considerable complexity associated with SMCC reactions, as informed by many independent mechanistic studies over the years, one can bring out essential trends through detailed data analysis. In this study, we have taken an open reaction data set reported by Pfizer and evaluated the properties of closely related substrates and the effect of the reaction solvent, base, and ligands. Through a detailed analysis of the reaction outcomes, we have focused on the occurrence of a common side-product in SMCCs, resulting from protodeborylation of the organoboron coupling component. There is considerable benefit in exploring the main cross-coupled product yield compared with the amount of protoborylated compound formed. In our analysis, we have delineated several key and interesting trends, which reveal value in evaluating side-product(s)/main product yields. A Shiny app has been developed for the rapid evaluation of the SMCC reaction data set.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.